Marine peptides for preventing metabolic syndrome

Current Protein and Peptide Science

Volumn 14, Issue 3, 2013, Pages 183-188

  Ko, Seok Chun ^a   Jeon, You Jin ^a  

^a Jeju National University   (South Korea)

Author keywords

Bioactive peptides; Cardiovascular diseases; Marine organisms; Metabolic syndrome

Indexed keywords

ALACEPRIL; BENAZEPRIL; CAPTOPRIL; ENALAPRIL; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; ENDOTHELIUM DERIVED RELAXING FACTOR; GAMMA INTERFERON; MARINE PEPTIDE; PEPTIDE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ZOFENOPRIL;

ANTIDIABETIC ACTIVITY; ANTIHYPERTENSIVE ACTIVITY; APOPTOSIS; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; COUGHING; DIABETES MELLITUS; DISEASE ASSOCIATION; DOWN REGULATION; HEART FAILURE; HUMAN; HYPERTENSION; INCIDENCE; METABOLIC SYNDROME X; NONHUMAN; OBESITY; OXIDATIVE STRESS; RASH; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TASTE DISORDER; VASODILATATION;

AMINO ACID SEQUENCE; ANIMALS; ANTI-OBESITY AGENTS; ANTIHYPERTENSIVE AGENTS; AQUATIC ORGANISMS; HUMANS; HYPOGLYCEMIC AGENTS; METABOLIC SYNDROME X; MOLECULAR SEQUENCE DATA; PEPTIDES;

EID: 84888253455     PISSN: 13892037     EISSN: 18755550     Source Type: Journal    
DOI: 10.2174/13892037113149990038     Document Type: Article

References (63)

1. Ngo, D.H.; Vo, T.S.; Ngo D.N.; Wijesekara, I.; Kim S. K; Biological activities and potential health benefits of bioactive peptides derived from marine organisms. Int. J. Biol. Macromol., 2012, In press.
2. Aneiros, A.; Garateix, A.; Bioactive peptides from marine sources: pharmacological properties and isolation procedures. J. Chromatogr. B, 2004, 803, 41-53.
3. Kim, S.K.; Wijesekara I.; Development and biological activities of marine-derived bioactive peptides: A review. J. Func. Food, 2010, 2, 1-9.
4. 2-induced cell damage. Fish Aqua. Sci., 2010, 13, 26-35.
5. Wijesinghe, W.A.J.P.; Jeon, Y. J; Exploiting biological activities of brown seaweed Ecklonia cava for potential industrial applications: a review. Int. J. Food Sci. Nutr., 2012, 63, 225-235.
6. Agyei, D.; Danquah, M.K.; Rethinking food-derived bioactive peptides for antimicrobial and immunomodulatory activities. Trends Food Sci. Tech., 2012, 23, 62-69.
7. Korhonen, H.; Pihlanto, A. Bioactive peptides: production and functionality. Int. Dairy J., 2006, 16, 945-960.
8. Fahmi, A.; Morimura, S.; Guo, H.C.; Shigematsu, T.; Kida, K.; Ueyama, Y. Production of angiotensin I converting enzyme inhibitory peptides from sea bream scales. Process Biochem., 2004, 39, 1195-1200.
9. Lahl, W.J.; Braun, S.D. Enzymatic production of protein hydrolysate for food use. Food Technol., 1994, 48, 68-71.
10. Lee, J.K.; Jeon, J.K.; Byun, H.G. Effect of angiotensin I converting enzyme inhibitory peptide purified from skate skin hydrolysate. Food Chem., 2011, 125, 495-499.
11. Ko, S.C.; Lee, J.K.; Byun, H.G.; Lee, S.C.; Jeon, Y.J. Purification and characterization of angiotensin I-converting enzyme inhibitory peptide from enzymatic hydrolysates of Styela clava flesh tissue. Process Biochem., 2012, 47, 34-40.
12. ko, S.C.; Kim, D.G.; Han, C.H.; Lee, Y.J.; Lee, J.K.; Byun, H.G.; Lee, S.C.; Park, S.J.; Lee, D.H.; Jeon, Y.J. Nitric oxide-mediated vasorelaxation effects of anti-angiotensin I-converting enzyme (ACE) peptide from Stylea clava flesh tissue and its antihypertensive effect in spontaneously hypertensive rats. Food Chem., 2012, 134, 1141-1145.
13. Lee, J.K.; Hong, S.; Jeon, J.K.; Kim, S.K.; Byun, H.G. Purification and characterization of angiotensin I converting enzyme inhibitory peptides from the rotifer, Brachionus rotundifirmis. Bioresource Technol., 2009, 100, 5255-5259.
14. Zhao, Y.; Li, B.; Dong, Z.; Zhao, X.; Zeng, M. Antihypertensive effect and purification of an ACE inhibitory peptide from sea cucumber gelatin hydrolysate. Process Biochem., 2007, 42, 1586-1591.
15. Ko, S.C.; Kim, D.; Jeon, Y.J. Protective effect of a novel antioxidative peptide purified from a marine Chlorella ellisoidea protein against free radical-induced oxidative stress. Food Chem. Toxicol., 2012, 50, 2294-2302.
16. Bougatef, A.; Nedjar-Arroume, N.; Manni, L.; Ravallec, R.; Barkia, A.; Guillochon, D.; Nasri, M. Purification and identification of novel antioxidant peptide from enzymatic hydrolysates of sardinelle (Sardinella aurita) by-products proteins. Food Chem., 2010, 118, 559-565.
17. Jo, H.Y.; Jung, W.K.; Kim, S.K. Purification and characterization of a novel anticoagulant peptide from marine echiuroid worm, Urechis unicinctus. Process Biochem., 2008, 43, 179-184.
18. Rajapakse, N.; Jung, W.K.; Mendis, E.; Moon, S.H.; Kim, S.K. A novel anticoagulant purified from fish protein hydrolysate inhibits factor XIIa and platelet aggregation. Life Sci., 2005, 76, 2507-2619.
19. Zhu, C.F.; Peng H.B.; Liu G.Q.; Zhang, F.; Li Y. Beneficial effects of oligopeptides from marine salmon skin in a rat model of type 2 diabetes. Nutrition, 2010, 26, 1014-1020.
20. Zhu, C.F.; Li, G.Z.; Peng, H.B.; Zhang F.; Chen, Y.; Li, Y. Effect of marine collagen peptides on markers of metabolic nuclear receptors in type 2 diabetic patients with/without hypertension. Biomed. Environ. Sci., 2010, 23, 113-120.
21. Cudennec, B.; Ravallec-Plé, R.; Courois, E.; Fouchereau-Peron, M. Peptides from fish and crustacean by-products hydrolysates stimulate cholecystokinin release in STC-1 cells. Food Chem., 2008, 111, 970-975.
22. Alberti, KG.; Zimmet, P.; Shaw, J. IDF Epidemiology Task Force Consensus Group. The metabolic syndrome new worldwide definition. Lancet, 2005, 366, 1059-1062.
23. Alberti, K.G.; Zimmet, P.; Shaw, J. Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet. Med., 2006, 23, 469-480.
24. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA., 2001, 285, 2486-2497.
25. Je, J.Y.; Park, J.Y.; Jung, W.K.; Park, P.J.; Kim. S.K. Isolation of angiotensin I converting enzyme (ACE) inhibitor from fermented oyster sauce, Crassostrea gigas. Food Chem., 2005, 90, 809-814.
26. Lee, S.H.; Qian, Z.J.; Kim, S.K. A novel angiotensin I converting enzyme inhibitory peptide from tuna frame protein hydrolysate and its antihypertensive effect in spontaneously hypertensive rats. Food Chem., 2010, 118, 96-102.
27. Bohr, D.F.; Dominiczak, A.F.; Webb, R.C. Pathophysiology of the vasculature in hypertension. Hypertension, 1991, 18(suppl 111), S69-S75.
28. Je, J.Y.; Park, P.J.; Byun H.G.; Jung, W.K.; Kim, S.K. Angiotensin I converting enzyme (ACE) inhibitory peptide derived from the sauce of fermented blue mussel, Mytilus edulis. Bioresource Technol. 2005, 96, 1624-1629.
29. Ondetti, MA. Design of specific inhibitors of angiotensin converting enzyme: New class of orally active antihypertensive agents. Science, 1977, 196, 441-444.
30. Kato, H.; Suzuki T. Bradykinin-potentiating peptides from the venom of Agkistrodon halys blomhoffii: Isolation of five bradykinin potentiators B and C. Toxicon., 1972, 10, 313.
31. Kamiya, A.; Ando, J.; Shibata, M.; Masuda, H. Roles of fluid shear stress in physiological regulation of vascular structure and function. Biorheology, 1998, 25, 272-278.
32. Ko, S.C.; Kang, M.C.; Lee, J.K.; Byun, H.G.; Kim, S.K.; Lee, S.C.; Jeon, B.T.; Park, P.J.; Jung, W.K.; Jeon, Y.J. Effect of angiotensin I-converting enzyme (ACE) inhibitory peptide purified from enzymatic hydrolysates of Styela plicata. Eur. Food Res. Technol., 2011, 233, 915-922.
33. Jung, W.K.; Mendis, E.; Je, J.Y.; Park, P.J.; Son, B.W.; Kim, H.C.; Choi, Y.K.; Kim, S.K. Angiotensin I-converting enzyme inhibitory peptide from yellowfin sole (Limanda aspera) frame protein and its antihypertensive effect in spontaneously hypertensive rats. Food Chem., 2006, 94, 26-32.
34. Tsai J.S.; Chen, J.L.; Pan B.S. ACE-inhibitory peptides identified from the muscle protein hydrolysate of hard clam (Meretrix lusoria). Process Biochem., 2008, 43, 743-747.
35. Wang, J.; Hu, J.; Cui, J.; Bai, X.; Dua, Y.; Miyaguchi, Y.; Lin, B. Purification and identification of a ACE inhibitory peptide from oyster proteins hydrolysate and the antihypertensive effect of hydrolysate in spontaneously hypertensive rats. Food Chem., 2008, 111, 302-308.
36. Byun, H.G.; Kim, S.K. Purification and characterization of angiotensin I converting enzyme (ACE) inhibitory peptides from Alaska pollack (Theragra chalcogramma) skin. Process Biochem., 2001, 36, 1155-1162.
37. Je, J.Y.; Park, P.J.; Kwon, J.Y.; Kim, S.K. A novel angiotensin I converting enzyme inhibitory peptide from Alaska pollack (Theragra chalcogramma) frame protein hydrolysate. J. Agr. Food Chem., 2004, 52, 7842-7845.
38. Suetsuna, K.; Maekawa, K.; Chen, J.R. Antihypertensive effects of Undaria pinnatifida (wakame) peptide on blood pressure in spontaneously hypertensive rats. J. Nutr. Biochem., 2004, 15, 267-272
39. Fahmi, A.; Morimura, S.; Guo, H.C.; Shigematsu, T.; Kida, K.; Uemura, Y. Production of angiotensin I converting enzyme inhibitory peptides from sea bream scales. Process Biochem., 2004, 39, 1195-1200.
40. Wu, H.; He, H.L.; Chen, X.L.; Sun, C.Y.; Zhang, Y.Z.; Zhou, B.C. Purification and identification of novel angiotensin-I-converting enzyme inhibitory peptides from shark meat hydrolysate. Process Biochem., 2008, 43, 2008, 457-461.
41. Asselbergs, F.W.; Harst, P.; Jessurum, G.A.J.; Tio, R.A.; van Gilst, W.H. 2005. Clinical impact of vasomotor function assessment and the role of ACE-inhibitors and statins. Vasc. Pharmacol., 2005, 42, 125-140.
42. Furchgott, R.F.; Zawadzki, J.V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature, 1980, 288, 373-376.
43. Beny, J.L.; Brunet, P.C. Electrophysiological and mechanical effects of substance P and acetylcholine on rabbit aorta. J. Physiol., 1988, 398, 277-289.
44. Moncada, S., & Vane, J. R. (1978). Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2 and prostacyclin. Pharmacol. Rev., 30, 293-331.
45. Kim, H.Y.; Oh, H.; Li, X.; Cho, K.W.; Kang, D.G.; Lee, H.S. Ethanol extract of seeds of Oenothera odorata induces vasorelaxation via endotheliump-dependent NO-cGMP signaling through activation of Akt-eNOS-sGC pathway. J. Ethnophamacol., 2011, 133, 315-323.
46. Schmitt, C.A.; Dirsch, V.M. Modulation of endothelial nitric oxide by plant-derived products. Nitric Oxide, 2009, 21, 77-91.
47. Clozel, M.; Kuhn, H.; Hefti, F. Effects of angiotensin converting enzyme inhibitors and of hydralazine on endothelial function in hypertensive rats. Hypertension, 1990, 16, 532-540.
48. Hayakawa, H.; Coffee, K.; Raij, L. Endothelial dysfunction and cardiorenal injury in experimental salt-sensitive hypertension: effects of antihypertensive therapy. Circulation, 1990, 96, 2407-2413.
49. Zhao, Y.; Li, B.; Dong, S.; Liu, Z.; Zhao, X.; Wang, J.; Zeng, M. A novel ACE inhibitory peptide isolated from Acaudina moladioidea hydrolysate. Peptides, 2009, 30, 1028-1033.
50. Lee, S.H.; Park, M.H.; Heo, S.J.; Kang, S.M.; Ko, S.C.; Han, J.S.; Jeon, Y.J. Dieckol isolated from Ecklonia cava inhibits α-glucosidase and α-amylase in vitro and alleviates postprandial hyperglycemia in streptozotocin-induced diabetic mice. Food Chem. Toxicol., 2010, 48, 2633-2637.
51. Lee, S.H.; Min, K.H.; Han, J.S.; Lee, D.H.; Park, D.B.; Jung, W.K.; Park, P.J.; Jeon, B.T.; kim, S.K.; Jeon, Y.J. Effects of brown alga, Ecklonia cava on glucose and lipid metabolism in C57BL/KsJdb/ db mice, a model of type 2 diabetes mellitus. Food Chem. Toxicol., 2012, 50, 575-582.
52. Stumvoll, M.; Goldstein, B.J.; van Haeften, T.W. Type 2 diabetes: principles of pathogenesis and therapy. Lancet, 2005, 365, 1333-1346.
53. Zimmet, P.; Alberti, K.; Shaw, J.; Global and societal implications of the diabetes epidemic. Nature, 2001, 414, 782-787.
54. Min, KH.; Kim, H.J.; Jeon, Y.J.; Han, J.S. Ishige okamurae ameliorates hyperglycemia and insulin resistance in C57BL/KsJ-db/db mice. Diabetes Res. Clin. PR., 2011, 93, 70-76.
55. Gloyn, A.L.; McCarthy, M.I. Genetics: how the UKPDS contributed to determining the genetic landscape of type 2 diabetes. Diabetes Med., 2008, 25(Suppl 2), 35-40.
56. Rashid, M.A.; Lee, S.; Tak, E.; Lee, J.; Choi, T.G.; Lee, J.W.; Kim, J.B.; Youn, J.H.; Kang, I.; Ha, J.; Kim, S.S. Carbonyl reductase 1 protects pancreatic β-cells against oxidative stress-induced apoptosis in glucotoxicity and glucolipotoxicity. Free Radical Bio. Med., 2010, 49, 1522-1533.
57. Lee, S.H.; Choi, J.I.; Heo, S.J.; Park, M.H.; Park, P.J.; Jeon, B.T.; Kim, S.K.; Han, J.S.; Jeon, Y.J. Diphlorethohydroxycarmalol isolated from Pae (Ishige okamurae) protects high glucose-induced damage in RINm5F pancreatic β cell via its antioxidant effects. Food Sci. Biotechnol., 2012, 2, 239-246.
58. Cnop, M.; Welsh, N.; Jonas, J.C.; Jo{double acute}rns, A.; Lenzen, S.; Eizirik, D.L. Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes, 2005, 54(Suppl 2), S97-107.
59. Kagi, D.; Odermatt, B.; Seiler, P.; Zinkernagel, R.M.; Mak, T.W.; Hengartner, H. Reduced incidence and delayed onset of diabetes in perforin-deficient nonobese diabetic mice. J. Exp. Med., 1997, 186, 989-97.
60. Hu, G.; Qiao, Q.; Tuomilehto, J.; Eliasson, M.; Feskens, E.J.; Pyörälä, K. Plasma insulin and cardiovascular mortality in nondiabetic European men and women: a meta-analysis of data from eleven prospective studies. The DECODE Insulin Study Group. Diabetologia, 2004, 47, 1245-1256.
61. Lee, I.; Manson, J.E.; Hennekens, C.H.; Paffenbarger, R.S. Body weight and mortality. A 27-year follow-up of middle-aged men. JAMA, 1993, 270, 2823-2828.
62. Ohlson, L.O.; Larsson, B.; Svardsudd, K.; Welin, L.; Eriksson, H.; Wilhelmsen, L.; Björntorp, P.; Tibblin, G. The influence of body fat distribution on the incidence of diabetes mellitus: 13.5years of follow-up of the participants in the study of men born in 1913. Diabetes, 1985, 34, 1055-1058.
63. Pouliot, M.C.; Després, J.P.; Lemieux, S.; Moorjani, S.; Bouchard, C.; Tremblay, A.; Nadeau, A.; Lupien P.J. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am. J. Cardiol., 1994, 73, 460-468.